Alexion Pharmaceuticals (ALXN)

Add to Watchlists Create an Alert
99.16 -0.71  -0.72%   NASDAQ May 24, 5:00PM BATS Real time Currency in USD

Alexion Pharmaceuticals R&D Expense Quarterly:

74.54M for March 31, 2013
View Full Chart

Alexion Pharmaceuticals R&D Expense Quarterly Chart

    Alexion Pharmaceuticals Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 74.54M
    Dec. 31, 2012 63.41M
    Sept. 30, 2012 54.28M
    June 30, 2012 59.64M
    March 31, 2012 45.41M
    Dec. 31, 2011 34.40M
    Sept. 30, 2011 36.57M
    June 30, 2011 35.65M
    March 31, 2011 30.81M
    Dec. 31, 2010 27.18M
    Sept. 30, 2010 25.15M
    June 30, 2010 23.69M
    March 31, 2010 22.37M
    Dec. 31, 2009 23.22M
    Sept. 30, 2009 21.32M
    June 30, 2009 18.29M
    March 31, 2009 19.09M
    Dec. 31, 2008 15.28M
    Sept. 30, 2008 14.87M
    June 30, 2008 16.82M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Oct. 31, 2005 Go Pro
    July 31, 2005 Go Pro
    April 30, 2005 Go Pro
    Jan. 31, 2005 Go Pro
    Oct. 31, 2004 Go Pro
    July 31, 2004 Go Pro
    April 30, 2004 Go Pro
    Jan. 31, 2004 Go Pro
    Oct. 31, 2003 Go Pro
    July 31, 2003 Go Pro
    April 30, 2003 Go Pro
    Jan. 31, 2003 Go Pro
    Oct. 31, 2002 Go Pro
    July 31, 2002 Go Pro
    April 30, 2002 Go Pro
    Jan. 31, 2002 Go Pro
    Oct. 31, 2001 Go Pro
    July 31, 2001 Go Pro
    April 30, 2001 Go Pro
    Jan. 31, 2001 Go Pro
    Oct. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ALXN R&D Expense Quarterly Benchmarks

    Companies
    Vertex Pharmaceuticals 218.10M
    Regeneron Pharmaceuticals 180.30M
    Athersys 4.935M

    ALXN R&D Expense Quarterly Rankings

    Overall 98th percentile
    153 of 8009
    Sector 94th percentile
    40 of 687 in Healthcare
    Industry 95th percentile
    12 of 248 in Biotechnology

    ALXN R&D Expense Quarterly Range, Past 5 Years

    Minimum 14.87M Sep 2008
    Maximum 74.54M Mar 2013
    Average 33.10M